1420 related articles for article (PubMed ID: 32428551)
1. Reply to the Letter to the Editor 'Germline-somatic fluidity in guiding patient care. Reply to the Letter to the Editor "Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients" by J. C. Rubinstein et al.' by E. Hahn & G. S. Charames.
Christison-Lagay ER; Rubinstein JC
Ann Oncol; 2020 Aug; 31(8):1090-1091. PubMed ID: 32428551
[No Abstract] [Full Text] [Related]
2. Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients.
Rubinstein JC; Nicolson NG; Rottmann D; Morotti R; Korah R; Carling T; Christison-Lagay ER
Ann Oncol; 2020 Jun; 31(6):815-821. PubMed ID: 32165204
[TBL] [Abstract][Full Text] [Related]
3. Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families.
Cirello V; Colombo C; Persani L; Fugazzola L
Int J Cancer; 2019 Jul; 145(2):600. PubMed ID: 30828786
[No Abstract] [Full Text] [Related]
4. Germline-somatic fluidity in guiding patient care.
Hahn E; Charames GS
Ann Oncol; 2020 Aug; 31(8):1089-1090. PubMed ID: 32387416
[No Abstract] [Full Text] [Related]
5. Identification of Rare Variants Predisposing to Thyroid Cancer.
Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
[No Abstract] [Full Text] [Related]
6. Letter to editor in response to article entitled "Recurrence in patients with clinically early-stage papillary thyroid carcinoma according to tumor size surgical extent" by Kim JW et al published in Am J Surg. 2016 Sep;212(3):419-425.e1. doi: 10.1016/j.amjsurg.2015.12.015.
Jha CK; Yadav SK; Bichoo RA
Am J Surg; 2017 Jul; 214(1):158. PubMed ID: 28468727
[No Abstract] [Full Text] [Related]
7. Papillary thyroid cancer in a patient with germline CHEK2 mutation: A case report.
da Silva Santos T; Tkachenko N; Couto de Carvalho A
Ann Endocrinol (Paris); 2021 Dec; 82(6):624-626. PubMed ID: 34555328
[No Abstract] [Full Text] [Related]
8. Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
Ni Y; Seballos S; Ganapathi S; Gurin D; Fletcher B; Ngeow J; Nagy R; Kloos RT; Ringel MD; LaFramboise T; Eng C
Endocr Relat Cancer; 2015 Apr; 22(2):121-30. PubMed ID: 25694510
[TBL] [Abstract][Full Text] [Related]
9. [The co-relation of BRAF V600E mutation and factors affecting occurrence and prognosis of papillary thyroid carcinoma].
Wang J; Liu LT; Cui D; He L; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):288-292. PubMed ID: 30955264
[No Abstract] [Full Text] [Related]
10. [Clinicopathological molecular genetic characteristics of columnar cell variant of papillary thyroid carcinoma].
Gu HY; Wang LL; Li GQ; Zhao H; Wang Y; Zhao J; Lin DL; Wang JG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1257-1259. PubMed ID: 34719164
[No Abstract] [Full Text] [Related]
11. Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review.
Chruścik A; Lam AK
Exp Mol Pathol; 2015 Dec; 99(3):393-8. PubMed ID: 26321247
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways.
Liu H; Chen X; Lin T; Chen X; Yan J; Jiang S
J Cell Physiol; 2019 Aug; 234(10):18382-18391. PubMed ID: 30941771
[TBL] [Abstract][Full Text] [Related]
13. [Histopatological and molecular genetic characteristics of clinically aggressive variants of papillary thyroid carcinoma].
Bogolyubova AV; Abrosimov AY; Selivanova LS; Belousov PV
Arkh Patol; 2019; 81(1):46-51. PubMed ID: 30830105
[TBL] [Abstract][Full Text] [Related]
14. Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.
Kure S; Wada R; Naito Z
Med Mol Morphol; 2019 Dec; 52(4):181-186. PubMed ID: 30788603
[TBL] [Abstract][Full Text] [Related]
15. Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.
Rubinstein JC; Brown TC; Christison-Lagay ER; Zhang Y; Kunstman JW; Juhlin CC; Nelson-Williams C; Goh G; Quinn CE; Callender GG; Udelsman R; Lifton RP; Korah R; Carling T
BMC Cancer; 2016 Aug; 16():646. PubMed ID: 27538953
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2.
Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195
[TBL] [Abstract][Full Text] [Related]
17. Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid Carcinoma: Molecular Characterization by Next-Generation Sequencing and Histopathological Comparison With Tall Cell Papillary Carcinoma of Thyroid.
Zhong E; Scognamiglio T; D'Alfonso T; Song W; Tran H; Baek I; Hoda SA
Int J Surg Pathol; 2019 Apr; 27(2):134-141. PubMed ID: 30227763
[TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A
Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
